Managing type 2 diabetes in people with advanced chronic kidney disease (CKD) and end-stage kidney disease (ESKD) on dialysis presents unique clinical challenges. With the 2026 Standards of Care increasingly shifting the focus toward cardio-renal outcomes, many clinicians are asking: how far can we go safely with GLP‑1 receptor agonists …
Read More »Kidney Protection in Diabetes: Using SGLT2s and GLP‑1s Early
As the burden of diabetic kidney disease (DKD) continues to grow, so does the urgency for early, evidence-based interventions. The concept of kidney protection diabetes is shifting—clinicians are now encouraged to initiate therapy before substantial kidney function loss occurs. Two major drug classes—SGLT2 inhibitors and GLP‑1 receptor agonists—are leading …
Read More »Cardiorenal-Metabolic Disease in Focus: Applying the CKM Framework in Diabetes Practice
The CKM framework in diabetes care—focusing on cardiovascular, kidney, and metabolic health—is more than a trend. It’s a clinical necessity. The ADA’s 2025 Standards of Care urge clinicians to manage these overlapping risks together, not separately. Why? Because patients with diabetes deserve outcomes that go beyond just A1C. This article …
Read More »When Diabetes Isn’t the Main Problem: Managing Comorbidities Without Losing Focus
Living with type 2 diabetes often means managing more than just blood glucose. For many patients, conditions like cardiovascular disease, chronic kidney disease, or depression take center stage in their care plan. When diabetes isn’t the main problem, how do you keep glucose control on track without compromising treatment for …
Read More »Diabetic Neuropathy: Comprehensive Insights for Healthcare Professionals
Explore comprehensive insights into diabetic neuropathy for healthcare professionals, focusing on diagnosis, pathophysiology, and effective management strategies.
Read More »Addressing the Challenge of Diabetic Kidney Disease: From Diagnosis to Management
Diabetic kidney disease is a serious complication of diabetes that can lead to end-stage kidney failure. It is one of the leading causes of morbidity and mortality among individuals with diabetes. As such, it is critical to understand the diagnosis and management of diabetic kidney disease in order to ensure …
Read More »Microvascular Complications in Diabetes: Screening and Management
Diabetes is a chronic condition affecting millions of people worldwide. One of the most serious complications of diabetes is microvascular disease, which can cause damage to the small blood vessels in the body and lead to a range of serious health problems. To help prevent and manage microvascular complications, it …
Read More »Managing Diabetes and Chronic Kidney Disease
Diabetes and chronic kidney disease (CKD) are two of the most common chronic illnesses in the world. Both can have serious consequences if left untreated, but proper management can help reduce the risk of further complications. This article will provide an overview of diabetes and CKD, discuss risk factors for …
Read More »Young Age at diabetes diagnosis amplifies the effect of diabetes duration on risk of chronic kidney disease
Young age at diagnosis or disease aggression which increases lifetime risk of CKD in type 2 patients with diabetes Type 2 Diabetes, once considered a disease that comes about at an older age, is now increasingly diagnosed in younger adults. The number of people between the ages of 20-39 years …
Read More »The Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone: A New Option for Patients with Diabetic Kidney Disease
Allison S. Rembert, PharmD Candidate 2024 Adrian K. Baker, PharmD Candidate 2024 Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Department of Pharmacotherapy College of Pharmacy and Pharmaceutical Sciences Washington State University A 55-year-old female with type 2 diabetes (T2D) and chronic kidney disease (CKD) presented to the ambulatory care clinic. …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.